Fig. 4From: Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell linesChanges in expression of apoptotic regulators and cellular signaling after combined treatment with Romidepsin and JQ1. Relative mRNA expression levels of antiapoptotic BCL-XL (a) and BCL-2 (b) and proapoptotic BCL-XS (c). mRNA levels were measured by qRT-PCR and normalized to the expression of TBP. Fold change compared to DMSO control 48 h after treatment is displayed on the ordinate. Differences between combination treatment samples and untreated controls were analyzed using Student’s t test (**p ≤ 0.01, *p ≤ 0.05). d Protein expression of antiapoptotic BCL-XL and Survivin after combination treatment for 48 h assessed by Western blot. e Protein expression of c-MYC, EZH2, p57KIP2, and phospho-p57KIP2 (Thr310) assessed by Western blot analysis. f Phosphorylated AKT (S473) and expression of AKT and SKP2 was detected by Western blot analysisBack to article page